Literature DB >> 17184751

Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat.

Simon Nagel1, Just Genius, Sabine Heiland, Solveig Horstmann, Humphrey Gardner, Simone Wagner.   

Abstract

Diphenyleneiodonium (DPI) is an inhibitor of the free radical producing NAD(P)H-oxidase. We tested whether DPI shows neuroprotective properties after focal cerebral ischemia and we used dimethylsulfoxide (DMSO), a nonspecific free radical scavenger, as a solvent. In male Wistar rats middle cerebral artery occlusion (1.5 h) and subsequent reperfusion (48 h) (MCAO/R) was induced with the filament model. Immediately after reperfusion the animals received either 0.25 ml normal saline, DMSO, or a combination of DMSO and DPI; each group consisted of 10 animals. MRI was performed at different times after reperfusion. Gelatine zymography of brain tissue for MMP-2 and MMP-9 was performed. The infarct sizes and BBB damage showed a significant difference between controls and the DPI/DMSO group for almost all points in time in all sequences. The activity of MMP-2 and MMP-9 was significantly reduced by DPI/DMSO but not by DMSO alone. DMSO treatment alone resulted in a protective effect with reduced lesion sizes measured by MRI at selected points of time, consistent with its known free radical scavenger effect. The combination of DMSO with DPI partly augmented this effect, presumably due to the additional inhibition of MMP-2 and MMP-9 by DPI. Moreover, the neurological outcome in both therapeutic groups was improved compared to controls with a significant difference between the therapeutic groups in favour of DPI and DMSO. The combination of DPI and DMSO reduced the activity of MMP-2 and MMP-9, attenuated the postischemic blood-brain barrier damage and improved neurological outcome. This was most likely due to reduced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184751     DOI: 10.1016/j.brainres.2006.11.023

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  NADPH oxidase in stroke and cerebrovascular disease.

Authors:  Xian Nan Tang; Belinda Cairns; Jong Youl Kim; Midori A Yenari
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

2.  An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury.

Authors:  Mengwei Wang; Le Luo
Journal:  Neurochem Res       Date:  2020-02-18       Impact factor: 3.996

Review 3.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 4.  Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.

Authors:  Kim A Radermacher; Kirstin Wingler; Friederike Langhauser; Sebastian Altenhöfer; Pamela Kleikers; J J Rob Hermans; Martin Hrabě de Angelis; Christoph Kleinschnitz; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

Review 5.  Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

Authors:  J Marc Simard; Zhihua Geng; Frank L Silver; Kevin N Sheth; W Taylor Kimberly; Barney J Stern; Mario Colucci; Volodymyr Gerzanich
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

6.  Dimethyl sulfoxide induces heme oxygenase-1 expression via JNKs and Nrf2 pathways in human umbilical vein endothelial cells.

Authors:  Chao Liang; Zhanggang Xue; Jing Cang; Hao Wang; Ping Li
Journal:  Mol Cell Biochem       Date:  2011-04-30       Impact factor: 3.396

7.  Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.

Authors:  Ananddeep Patel; Shaojie Zhang; Amrit Kumar Shrestha; Paramahamsa Maturu; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-08       Impact factor: 4.219

8.  Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.

Authors:  Antonio H Martins; Jing Hu; Zhenfeng Xu; Chaofeng Mu; Paloma Alvarez; Byron D Ford; Khalid El Sayed; Vesna A Eterovic; Pedro A Ferchmin; Jiukuan Hao
Journal:  Neuroscience       Date:  2015-02-10       Impact factor: 3.590

Review 9.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

Review 10.  The injured nervous system: a Darwinian perspective.

Authors:  Zachary M Weil; Greg J Norman; A Courtney DeVries; Randy J Nelson
Journal:  Prog Neurobiol       Date:  2008-06-14       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.